Breast Cancer Research and Treatment

, Volume 125, Issue 2, pp 511–517 | Cite as

Cadmium concentration in biological media of breast cancer patients

  • Loreta Strumylaite
  • Algirdas Bogusevicius
  • Olegas Abdrachmanovas
  • Dale Baranauskiene
  • Rima Kregzdyte
  • Darius Pranys
  • Lina Poskiene
Epidemiology

Abstract

The study aimed to determine and compare cadmium (Cd) concentration in different biological media of breast cancer and benign breast tumor patients. Concentration of Cd was determined in breast tissue, urine, and blood of 57 breast cancer and 51 benign tumor patients. Two samples of breast tissue from each patient, i.e., tumor and healthy tissue were taken for the analysis. Cd in biological media was determined by atomic absorption spectrometry (Perkin–Elmer, Zeeman 3030). The mean Cd concentration in breast cancer patients was 0.053 μg/g (95% confidence intervals, CI 0.042–0.065) for tumor sample and 0.02 μg/g (95% CI 0.014–0.026) for healthy breast tissue sample (P < 0.001). In benign tumor patients, the figures were as follows: 0.037 μg/g (95% CI 0.023–0.051) and 0.032 μg/g (95% CI 0.018–0.047) (P > 0.05). Cd content in malignant tumor significantly differed from that in benign tumor (P < 0.01). Cancer patients with positive estrogen receptors (ERs) had significantly greater concentration of breast tissue Cd compared to patients with negative ERs (P = 0.035). Adjusted for creatinine, Cd in urine was significantly higher in cancer patients than in controls (P < 0.001). In cancer patients, a positive Spearman’s correlation was found between Cd in tumor and healthy breast tissue, blood (r = 0.44 and r = 0.39, respectively, P < 0.01). Correlation between Cd in urine of cancer patients and number of cigarettes smoked during lifetime was suggestive (r = 0.59, P = 0.075). The data obtained show higher concentration of cadmium in breast tumor and urine of cancer patients and support a possible relationship between cadmium and breast cancer.

Keywords

Cadmium Breast tissue Urine Blood Breast cancer Hormone receptors 

Notes

Acknowledgment

This study was supported by a grant from the Lithuanian State Science and Studies Foundation (No. T-64/09).

References

  1. 1.
    IARC (1993) Monographs on the evaluation of carcinogenic risks to humans. IARC, Lyon, pp 119–237Google Scholar
  2. 2.
    Joseph P (2009) Mechanisms of cadmium carcinogenesis. Toxicol Appl Pharmacol 238:272–279. doi:10.1016/j.taap.2009.01.011 CrossRefPubMedGoogle Scholar
  3. 3.
    Achanzar WE, Diwan BA, Liu J, Quader ST, Webber J, Waalkes MP (2001) Cadmium-induced malignant transformation of human prostate epithelial cells. Cancer Res 61:455–458PubMedGoogle Scholar
  4. 4.
    Achanzar WE, Webber MW, Waalkes MP (2002) Altered apoptotic gene expression and acquired apoptotic resistance in cadmium-transformed human epithelial cells. Prostate 52:236–244. doi:10.1002/pros.10106 CrossRefPubMedGoogle Scholar
  5. 5.
    Vinceti M, Venturelli M, Sighinolfi C, Trerotoli P, Bonvicini F, Ferrari A, Bianchi G, Serio G, Bergomi M, Vivoli G (2007) Case-control study of toenail cadmium and prostate cancer risk in Italy. Sci Total Environ 373:77–81. doi:10.1016/j.scitotenv.2006.11.005 CrossRefPubMedGoogle Scholar
  6. 6.
    Pesch B, Haerting J, Ranft U, Klimpel A, Oelschägel B, Schill W, MURC Study Group (2000) Occupational risk factors for renal cell carcinoma: agent-specific results from a case-control study in Germany. Int J Epidemiol 29:1014–1024CrossRefPubMedGoogle Scholar
  7. 7.
    Hu J, Mao Y, White K (2002) Renal cell carcinoma and occupational exposure to chemicals in Canada. Occup Med (London) 52:157–164CrossRefGoogle Scholar
  8. 8.
    Garcia-Morales P, Saceda M, Kenney N, Kim N, Salomon DS, Gottardis MM, Solomon HB, Sholler PF, Jordan VC, Martin MB (1994) Effect of cadmium on estrogen receptor levels and estrogen-induced responses in human breast cancer cells. J Biol Chem 269:16896–16901PubMedGoogle Scholar
  9. 9.
    McElroy JA, Shafer MM, Trentham-Dietz A, Hampton JM, Newcomb PA (2006) Cadmium exposure and breast cancer risk. J Natl Cancer Inst 98:869–872. doi:10.1093/jnci/djj233 CrossRefPubMedGoogle Scholar
  10. 10.
    Meplan C, Mann K, Hainaut P (1999) Cadmium induces conformational modifications of wild-type p53 and suppresses p53 response to DNA damage in cultured cells. J Biol Chem 274:31663–31670. doi:10.1074/jbc.274.44.31663 CrossRefPubMedGoogle Scholar
  11. 11.
    Abshire MK, Buzard GS, Shiraishi N, Waalkes MP (1996) Induction of c-myc and c-jun protooncogene expression in rat L6 myoblasts by cadmium is inhibited by zinc preinduction of the metallothionein gene. J Toxicol Environ Health 48:359–377CrossRefPubMedGoogle Scholar
  12. 12.
    Choe SY, Kim SJ, Kim HG, Lee JH, Choi Y, Lee H, Kim Y (2003) Evaluation of estrogenicity of major heavy metals. Sci Total Environ 312:15–21. doi:10.1016/S0048-9697(03)00190-6 CrossRefPubMedGoogle Scholar
  13. 13.
    Johnson MD, Kenney N, Stoica A, Hilakivi-Clarke L, Singh B, Chepko G, Clarke R, Sholler PF, Lirio AA, Foss C, Reiter R, Trock B, Paik S, Martin MB (2003) Cadmium mimics the in vivo effects of estrogen in the uterus and mammary gland. Nat Med 9:1081–1084. doi:10.1038/nm902 CrossRefPubMedGoogle Scholar
  14. 14.
    Stoica A, Katzenellenbogen BS, Martin MB (2000) Activation of estrogen receptor-alpha by the heavy metal cadmium. Mol Endocrinol 14:545–553CrossRefPubMedGoogle Scholar
  15. 15.
    Martin MB, Reiter R, Pham T, Avellanet YR, Camara J, Lahm M, Pentecost E, Pratap K, Gilmore BA, Divekar S, Dagata RS, Bull JL, Stoica A (2003) Estrogen-like activity of metals in Mcf-7 breast cancer cells. Endocrinology 144:2425–2436. doi:10.1210/en.2002-221054 CrossRefPubMedGoogle Scholar
  16. 16.
    Antila E, Mussalo-Rauhamaa H, Kantola M, Atroshi F, Westermarck T (1996) Association of cadmium with human breast cancer. Sci Total Environ 186:251–256. doi:10.1016/0048-9697(96)05119-4 CrossRefPubMedGoogle Scholar
  17. 17.
    Ionescu JG, Novotny J, Stejskal V, Latsch A, Blaurock-Busch E, Eisenmann-Klein M (2006) Increased levels of transition metals in breast cancer tissue. Neuroendocrinol Lett 27(Suppl. 1):36–39PubMedGoogle Scholar
  18. 18.
    Strumylaite L, Bogusevicius A, Ryselis S, Pranys D, Poskiene L, Kregzdyte R, Abdrakhmanov O, Asadauskaite R (2008) Association between cadmium and breast cancer. Medicina (Kaunas) 44:415–420Google Scholar
  19. 19.
    Instruction Manual (2006) Multiwave 3000. Microwave reaction system. Anton Paar GmbH, GrazGoogle Scholar
  20. 20.
    Schlemmer G (1989) Analysis of biological chemical materials by graphite furnace—AAS. In: Instrumentalized analytical chemistry and computer technology. GIT, Asfeld, pp 561–568Google Scholar
  21. 21.
    DAKO (1996) Reference in immunohistochemistry. Breast cancer diagnosis, therapy and prognosis, 3rd edn. 00079b/10000, Glostrup, DAKo A/S, pp 1–9Google Scholar
  22. 22.
    Elinder CG (1985) Normal values for cadmium in human tissues, blood, and urine in different countries. In: Friberg L, Elinder CG, Kjellstrom T, Nordberg GF (eds) Cadmium and health: a toxicological and epidemiological appraisal. Exposure, dose, and metabolism. CRC Press, Boca Raton, pp 81–102Google Scholar
  23. 23.
    Jaffe M (1986) Ueber den Niederschlag, welchen Pikrinsaure in normalen Harn erzeugt und uber eine neue Reaktion des Kreatininis. Hoppe Seylers Z Physiol Chem 10:391–400Google Scholar
  24. 24.
    Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P (2007) Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 18:581–592. doi:10.1093/annonc/mdl498 CrossRefPubMedGoogle Scholar
  25. 25.
    Coyle YM (2004) The effect of environment on breast cancer risk. Breast Cancer Res Treat 84:273–288. doi:10.1023/B:BREA.0000019964.33963.09 CrossRefPubMedGoogle Scholar
  26. 26.
    Key TJ, Verkasalo PK, Banks E (2001) Epidemiology of breast cancer. Lancet 2:133–140. doi:10.1016/S1470-2045(00)00254-0 CrossRefGoogle Scholar
  27. 27.
    Verkasalo PK, Kaprio J, Koskenvuo M, Pakkula E (1999) Genetic predisposition, environment and cancer incidence: a nationwide twin study in Finland, 1976–1995. Int J Cancer 83:743–749CrossRefPubMedGoogle Scholar
  28. 28.
    Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Kosenvuo M, Pukkula E, Skytthe A, Hemminki K (2000) Environmental and heritable factors in the causation of cancer. N Eng J Med 343:78–85CrossRefGoogle Scholar
  29. 29.
    IPCS (1992) Cadmium. Environmental health criteria 134. WHO, GenevaGoogle Scholar
  30. 30.
    Jarup L (2003) Hazards of heavy metal contamination. Br Med Bull 68:167–182. doi:10.1093/bmb/ldg032 CrossRefPubMedGoogle Scholar
  31. 31.
    Satarug S, Moore MR (2004) Adverse health effects of chronic exposure to low-level cadmium in foodstuffs and cigarette smoke. Environ Health Perspect 112:1099–1103. doi:10.1289/ehp.6751 CrossRefPubMedGoogle Scholar
  32. 32.
    Olsson IM, Eriksson J, Oborn I, Skerfving S, Oskarsson A (2005) Cadmium in food production systems: a health risk for sensitive population groups. J Hum Environ 34:344–351Google Scholar
  33. 33.
    EEC-European Council Regulation (2001) Commission Regulation (EC) No 466/2001 of 8 March 2001 setting maximum levels for certain contaminants in food stuffs. Off J Eur Commun L 077:0001–0013Google Scholar
  34. 34.
    Elinder CG, Friberg L, Kjelstrom T, Nordberg G, Oberdoerster G (1994) Biological monitoring of the metals. WHO, GenevaGoogle Scholar
  35. 35.
    CDC (2005) Third national report on human exposure to environmental chemicals. Centers for Disease Control and Prevention, AtlantaGoogle Scholar
  36. 36.
    Satarug S, Ujjin P, Vanavanitkun Y, Baker JR, Moore MR (2004) Influence of body iron store status and cigarette smoking on cadmium body burden of healthy Thai women and men. Toxicol Lett 148:177–185. doi:10.1016/j.toxlet.2003.09.015 CrossRefPubMedGoogle Scholar
  37. 37.
    Nishijo M, Satarug S, Honda R, Tsuritani I, Aoshima K (2004) The gender differences in health effects of environmental cadmium exposure and potential mechanisms. Mol Cell Biochem 255:87–92. doi:10.1023/B:MCBI.0000007264.37170.39 CrossRefPubMedGoogle Scholar
  38. 38.
    Rosen PP (1996) Fibroepithelial neoplasms. In: Rosen PP (ed) Rosen’s breast pathology, 1st edn. Lippincott-Raven Press, New York, pp 143–155Google Scholar

Copyright information

© Springer Science+Business Media, LLC. 2010

Authors and Affiliations

  • Loreta Strumylaite
    • 1
  • Algirdas Bogusevicius
    • 2
  • Olegas Abdrachmanovas
    • 1
  • Dale Baranauskiene
    • 1
  • Rima Kregzdyte
    • 1
  • Darius Pranys
    • 3
  • Lina Poskiene
    • 3
  1. 1.Institute for Biomedical ResearchKaunas University of MedicineKaunasLithuania
  2. 2.Department of SurgeryKaunas University of MedicineKaunasLithuania
  3. 3.Department of Pathological AnatomyKaunas University of MedicineKaunasLithuania

Personalised recommendations